Preoperative Olaparib Endometrial Carcinoma Study (POLEN)

NCT02506816 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinoma

Interventions

DRUG: Olaparib

Sponsor

MedSIR

Collaborators

[object Object]
[object Object]